European Heart Journal

Article	Citations
Corrigendum to: Backup natural pacemaker found in the heart	2719
Residual leaks after transcatheter left atrial appendage closure: why and how to assess it?	2515
Intricacies of aortic risk assessment studies: not a simple matter	1930
Pulmonary haemodynamics and pulmonary congestion: where are we now?	1831
The Antwerp score: is this the ‘new hope on the horizon’?	1498
Female representation on editorial boards of the National Societies of Cardiology Journals of the European Society of Cardiology	1342
A rare case of a dorsal mass caused by descending thoracic aortic dissection	1105
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies	1103
Corrigendum to: Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled	973
Meet the European Society of Cardiology Gold Medallists 2022	888
Strengthening cardiovascular trials across Australia and New Zealand—the Alliance for Cardiovascular Trials (ANZACT) Network	814
Unmeasured confounding is always unnerving: cannabis and cardiovascular risk	812
Additional value of 18fluorodeoxyglucose positron emission tomography/computed tomography combined with intracardiac echocardiography to detect lead vegetations	789
Obituary Joep Perk	771
Taking inspiration from birds to improve flow in prosthetic heart valves: an European Research Council granted project	733
The extended role of 24 h ambulatory blood pressure monitoring for reflex syncope	497
Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure	447
A case of crowded heart: closing the door after the visitors	435
Isolated early peak cardiac troponin for clinical decision-making after elective cardiac surgery: useless at best	374
Doubly committed ventricular septal defect closure using an eccentric occluder via minimal incision in the anterior median sternum through the left parasternal third intercostal space	363
Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?	353
Weekly journal scan: a hard RAFTing to improve long-term survival in heart failure with severely reduced ejection fraction	329
Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies	311
ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure management	268
The European Cardio Summit in Romania	250

Expression changes of circulating ACE2 regulating-microRNA profiles in patients with COVID-19 during hospitalisation	232
Beyond modality: unaddressed variables and comorbidities in exercise interventions for coronary artery disease	230
Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry	220
Diffusion tensor imaging to assess myocardial microstructure after infarction by magnetic resonance	209
Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study	204
Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial	200
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle	194
Bulgarian Society of Cardiology: 50 years on	191
Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction	175
Arterial conduits for coronary bypass grafting: the set-point concept	174
Correction to: Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score	168
Toll-like receptor 2, hyaluronan, and neutrophils play a key role in plaque erosion: the OPTICO–ACS study	167
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54	167
Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up	164
Role of inflammation in Myocardial Infarction with Non-Obstructive Coronary Arteries	161
Synthetic assessment of cardiac autonomic modulation and Baevsky stress index in patients with synucleinopathies	161
Takotsubo syndrome is a coronary microvascular disease: experimental evidence	160
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology	159
Correction to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary sy	158
Air pollutants, genetic susceptibility, and abdominal aortic aneurysm risk: a prospective study	157
Do we need new thresholds for surgical repair in patients with ascending thoracic aortic aneurysm disease?	156
One-shot thrombolysis for the management of acute ischaemic stroke	155
Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial	150
Promising perspectives on pregnancy in women with congenital heart disease	148
Can we measurably improve the prediction of recurrent coronary artery disease events?	148
Suspected heart failure: a clinical pattern that calls for action	147
Why Y? The Y chromosome may serve a cardiovascular purpose after all	145
Hypernatremia and subclinical chronic kidney disease	143
Mischief in the marrow: a root of cardiovascular evil	143
The Year in Cardiovascular Medicine 2024: the top 10 papers in interventional cardiology	137
Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics	134
Association of Body mass index and clinical outcomes in patient with coronary artery disease undergoing percutaneous coronary intervention	131
Increased right amygdala activity during the hyper-acute phase of takotsubo syndrome	130
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation	130
Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab	128
Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records	128
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial	127
Beyond reproductive health: the cardiovascular risks of endometriosis	127
Global burden of metabolic diseases: data from Global Burden of Disease 2000-2019. A cosortium of metabolic disease	126
Activation patterns of intracellular signaling pathways in cardiac hypertrophy induced by different exercise modes in rats	126
Acromegaly and cardiovascular outcomes: a cohort study	126
Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies	126
Pericardiocentesis over 3 years at a tertiary referral Australian hospital	125
Proteomic cardiovascular risk assessment in chronic kidney disease	124
Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study	123
Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University	122
Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes	121
A smartphone based AI model to detect left ventricular systolic dysfunction on 12-lead ECG	120
Brugada syndrome: can polygenic risk scores help the clinician?	118
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-T	115

High resting coronary flow velocity predicts worse survival in chronic coronary syndromes	115
Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center	114
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy	113
Screening for subclinical atherosclerosis in patients clinically diagnosed with familial hypercholesterolemia and determination of imaging-guided patient management strategy	112
Characteristics and long-term ablation outcomes of supraventricular arrhythmias in hypertrophic cardiomyopathy: a 10-year, single-center experience	111
Effectiveness of empagliflozin in patients with heart failure and COPD: Results from EMPEROR-Preserved and EMPEROR-Reduced	110
Abnormal left-sided blood volume, wall shear stress & energy loss in patients with repaired Tetralogy of Fallot identified by 4D flow MRI	110
AD-9308 ameliorates the impacts of 4-HNE on the progress of pulmonary arterial hypertension in aldehyde dehydrogenase 2*1*2 knock-in mice	109
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up	109
Elevated markers of liver function are associated with poorer outcomes in HFREF: an analysis of DAPA-HF	107
Weekly Journal Scan: Angiography-derived fractional flow reserve or intravascular ultrasound to guide stenting of non-complex coronary lesions	106
Vericiguat: a QTc interval study in patients with coronary artery disease	106
Evaluating the effect of the antiPCSK9 vaccine on systemic inflammation and oxidative stress in CFA-challenged albino mice	106
Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation	103
Allied health professional-physician collaboration to enhance guideline-directed medical therapy of heart failure: expanding therapeutic opportunities	102
Impact of QRS complex fragmentation on all-cause mortality before and after cardiac resynchronization therapy	102
Regional distribution of diffuse fibrosis in the basal and mid-ventricular AHA segments in patients with type 2 diabetes	102
Ventriculo-arterial coupling parameters by cardiac magnetic imaging are associated with outcome in patients with a systemic right ventricle	99
The role of process mining tools in STEMI networks: where should we build a new primary PCI centre?	99
Disparities in the access to atrial fibrillation ablation in Denmark	99
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement	99
Coronary rotational atherectomy in patients with severe aortic stenosis	97
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement	97
Functinal assessment in Angina and Non-Obstructive Coronary Arteries (ANOCA) patients: from Microvascular Resistance Reserve (MRR) to different subtypes of Coronary Microvascular Dysfunction (CMD)	96
Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)	93
High-sensitivity C-reactive protein is associated with cardiac dysfunction and morbidity in a community-based cohort	93
Telomere length across spectrum of metabolic health	91
Efficacy of intravascular lithotripsy (IVL) in coronary stenosis with severe calcification: a systematic review and meta-analysis of 38 studies	90
Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017	89
Refining the prognosis of patients with AF using 3D transesophageal echocardiography of the left atrial appendage	88
Machine learning using cardiovascular magnetic resonance to predict cardiovascular events in patients with acute myocarditis	88
Association of liver dysfunction with outcomes after percutaneous coronary intervention - a systematic review and meta-analysis	88
Beyond secondary prevention drugs: added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome	87
Dementia in individuals with severe hypercholesterolemia: Korean nationwide cohort study	87
Location and impact of the infarct-related artery in acute coronary syndrome: insight from the Swiss SPUM- ACS cohort	86
Impact of co-morbidities on survival after heart transplant in females of childbearing age: analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry	86
Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation	86
Immortal Time Bias: the hidden confounder in assessing cardiosurgical treatment effects	86
Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging	85
What is there to EAARN with a CRT implantation? Predictive factors of mortality or clinical deterioration in patients receiving cardiac resynchronization therapy based on pre-implant factors	85
Extraction of leadless and tranvenous pacemakers: occurrence, causes and complications from a national US database	84
Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF	84
Factors for incorrect automated atrial fibrillation identification in large-scale screening	84
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure	83
Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?	83
iRight4Me: individualisation of P2Y12 inihibitors in the realworld practice - an interim report	83
Atrial fibrillation organisation correlates with ventricular response regularity in patients with persistent atrial fibrillation	83
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study	83
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation	82
Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy	82
Impact of aortic valve calcium score on conductive disturbances after transcatheter aortic valve implantation: a monocentre retrospective study	82
Impact of the thin-walled sheath on the distal radial artery occlusion: a randomized trial	82
Quantitative assessment of myocardial fibrosis by digital image analysis: an adjunctive tool for pathologist ground truth	82
Prognostic role of data transmitted by implanted cardiac electric devices in patients with advanced heart failure referred for heart transplantation	81
The role of seasonal influenza immunisation in cardiovascular care: a survey of cardiologists	80
Comparative study of the effects of left ventricular and biventricular pacing on indices of cardiac function and clinical status of heart failure patients: preliminary results of READAPT study	80
Ultra-processed food consumption and risk of cardiovascular mortality in Australia: preliminary results from prospective observational study	80
Dynamic changes of excessive trabeculation in dilated cardiomyopathy: a longitudinal cardiovascular magnetic resonance study	79
Acute deterioration in dyssynchrony and systolic function from Lot-CRT to LBBB pacing	79
Comparison of fully angiography-derived versus a hybrid of angiography and pressure-wire-derived approach to assess coronary microvascular resistance: the OxAMI-Hybrid study	78
The added value of advanced echocardiography in dilated cardiomyopathy: looking at the right heart	77
Prognosis of diastolic dysfunction in patients with preserved LVEF. Value of left atrial strain	77
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction	77
Trimethylamine N-oxide as a Novel Biomarker for Left Ventricular Diastolic Dysfunction and Functional Remodeling in ST-Elevation Myocardial Infarction Patients	76
Cumulative accelerometer-based sedentary time from childhood through young adulthood with progressive left ventricular remodelling in British youth: a 13-year longitudinal study	76
Less dementia in patients with newly diagnosed atrial fibrillation adhering with a clustering of healthy lifestyle behaviours: a nationwide population-based cohort study	75
Prediction of all-cause mortality in cardiovascular patients by using machine learning models	75
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis	74
Predictors of 1-year follow-up period MACE in patients with NSTEMI	74
Coronary lesions suggestive of kawasaki disease in young patients presenting with acute myocardial infarction	73
Correlation of Seattle Angina Questionnaire score and post-procedural outcomes in patients undergoing multi-vessel coronary intervention	72
Therapeutic components of an automated digital counselling intervention for chronic heart failure	72
Association between plasma desmosine, a marker of elastin degradation, and total atherosclerotic burden measured by whole body magnetic resonance angiography	72
Clinical characteristics and natural history of pre-adolescent non-syndromic hypertrophic cardiomyopathy	72
A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias	71
Ischemic stroke in patients with congenital heart disease and atrial fibrillation	71
Gender bias in ACS management	71
The specificity of cardiac troponin elevations for myocardial infarction declines with age	70
Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study	70
Phenotyping of heart failure with preserved ejection faction using health electronic records and echocardiography	70

Use of sirolimus-coated balloon in de novo small vessel coronary lesions; Long-term follow-up from a single centre registry	70
The bimodal rise and fall acute coronary syndromes curves paralleling COVID-19 outbreaks	70
Do health care physician need to risk their own lives? Time to change our own attitude towards recommended physical activity	69
Mortality and predictors of death in women and men with congestive heart failure of different types of cardiomyopathies	69
Concomitant real-time measurement and correlation of contact force to baseline local impedance and local impedance drops in RF ablation of left and right atrial procedures	69
Long-term follow-up of early leaflet thrombosis after transcatheter aortic valve replacement	68
The novel P-Wave Area index predicts low voltage areas in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation	68
Prognostic impact of the serial change of a systemic inflammation-nutrition index in patients with heart failure with preserved ejection fraction: insights from pursuit-hfpef registry	68
Eisenmenger syndrome: is it the same entity in adulthood and pediatric age?	68
Follow-up on new marker confirming the optimal status in the treatment of heart failure with reduced ejection fraction	68
How to predict myocardial injury in patients with large ischaemic burden identified during stress echocardiography?	67
Impact of a 12-week supervised exercise program on weight loss trajectory, daily physical activity levels and sedentary behaviors after bariatric surgery	67
Characterisation of metabolic phenotype in aortic stenosis: insights from a multi-parametric cardiac magnetic resonance study	67
NOAC in adult congenital heart disease patients: a single-center experience	66
Post-systolic shortening index by echocardiography evaluation of dyssynchrony in the non-dilated and hypertrophied left ventricle	66
Heart failure with reduced ejection fraction: predicting exercise intolerance with echocardiography	65
Right ventricular free wall longitudinal strain (RVFWSL) a new outcome predictor in patients candiate for TAVI	65
Combined cardiopulmonary test and exercise Doppler echocardiography in systemic sclerosis	65
Dynamic optimization of CRT pacing using a novel algorithm improves survival in a real-world cohort of patients	64
Microvascular dysfunction and absolute coronary blood flow after percutaneous coronary intervention of a chronic total occlusion	63
Prediction of early left ventricular recovery and adverse remodelling in patients with acute myocardial infarction: the role of non-invasive myocardial work evaluation	63
Long-term effects of coronavirus disease 2019 on the cardiovascular system: the CV COVID-19 registry	63
Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction	62
His bundle pacing: safety, performance, and clinical outcomes in a single centre experience	62
Staging cardiac damage in aortic valve disease: one size fits all?	62
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry	62
Myocardial performance is impaired in cardiac amyloidosis: role of myocardial work-derived parameter in differential diagnosis with phenocopies and prognostic implications	62
Human pericardial fluid exosomes regulate macrophage immunophenotype: new prospective for cardiovascular myocardium-epicardium crosstalk in coronary artery disease	61
Age differences in the association between arterial velocity pulse index and muscle sympathetic nerve activity in hypertensive patients	61
Validation of HAS-BELD scoring system and risk factors of bleeding with warfarin among non-valvular atrial fibrillation patients	61
New definition of hypotension in patients with reflex syncope using 24-hour ambulatory blood pressure monitoring (SynABPM Study)	61
Spontaneous, independent, single-center renal denervation registry of a resistant hypertension multidisciplinary team	60
Deep learning for fully automated echocardiographic measurements of left ventricular wall thickness and chamber dimensions in the parasternal long-axis view	60
Long-term outcomes in patients with left bundle branch block after transcatheter aortic valve replacement	59
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes	59
Management of hospital resources for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) - an approach to deescalate ?	59
Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis	59
Estrogen-induced phenotype in hiPSC-derived cardiomyocytes of a woman affected by both Long QT Syndrome Type 2 and Polycystic Ovary Syndrome	59
Outcomes of patients with high bleeding risks characteristics presenting with acute coronary syndrome undergoing percutaneous coronary intervention	58
Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria	58
The expression of selected microRNAs enables identification of patients with functional atrial tricuspid regurgitation. New insights into TR pathophysiology	58
Genome-wide association study of atrial fibrillation in 114,539 Finnish individuals reveals novel locus associated with cardiac remodelling	58
Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community	57
The role of bystander-initiated basic life support in exercise-related sudden cardiac arrest: a systematic review	57
Health-related quality of life in patients with recurrent pericarditis: results from RHAPSODY, a phase 3 study of rilonacept	57
Figuring out complete left ventricular reverse remodeling in tachycardiomyopathy	57
Sympathetic nerve activity changes following acute exposures to electronic and tobacco cigarette smoking in humans	57
Routine use of 3-dimensional zoom modality with 2-dimensional transesophageal echocardiography to decide the candidacy for transcatheter device closure of atrial septal defect	57
Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels	57
Computed tomography plaque analysis identifies residual inflammation in recent acute myocardial infarction patients	56
Cumulative prognostic effect of diabetes and myocardial injury in patients attended in the emergency room	56
Influence of lead extraction on tricuspid valve function	55
Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension	55
An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins	55
SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players	55
Bipolar ablation of refractory ventricular arrhythmias using a novel dedicated adapter. A multicenter study	55
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry	55
Uncontrolled diabetes predicts anxiety and depression in CAD patients	55
Further prognostic stratification in patients with oscillatory ventilation with exercise: is there more to it than just ups and downs?	54
Protective effects of different types of bariatric surgeries on myocardial ischemia-reperfusion injury in non-obese non-diabetic rats	54
Primary care screening and prevention of heart failure coordinated by cardiologist in rural areas	54
Targeting Neurofibromin 2 (NF2) prevents endothelial dysfunction in obesity: a study in mice and humans	54
Ablation therapies for paroxysmal atrial fibrillation: a systematic review and patient-level network meta-analysis	54
Pregnancy in women with hypertrophic cardiomyopathy: observational data from the tertiary referral center registry	54
Investigations regarding the role of NOS1AP in the heart using a conditional overexpression mouse model	53
Does incidental calcium deposition in non-cardiac CT scans predict cardiovascular morbidity and mortality in young adults? A retrospective study	53
Pulmonary artery aneurysm in pulmonary arterial hypertension associated with congenital heart disease	53
Associations between changing patterns of ST-T waves morphologies in rest electrocardiography and cardiovascular risk in an asymptomatic low risk population: a report from Ansan-Ansung cohort study	53
Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study	52
The impact of hydrostatic pressure on fractional flow reserve in saphenous vein grafts	52
Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study	52
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS	52
Cardiac reparative therapy with adipose graft transposition procedure (AGTP) improves electrophysiological remodeling of chronic myocardial infarction	52
Endocardial pacing compared to epicardial left ventricle pacing and right ventricle pacing: a single center long term experience in a pediatric population	51
Efficacy of controlvit as a complementary strategy in reducing hospitalizations in patients with heart failure. Randomized clinical trial	51
A novel technology for heart failure that utilizes the respiratory effort to shift fluids from the lung and alleviate cardiac workloads; feasibility study in sheep	51
Hemodynamic pulmonary response to exercise according to different resting pulmonary hypertension thresholds in chronic thromboembolic pulmonary disease	51
Influence of diabetes, heart failure, and NT-proBNP on cardiovascular outcomes in patients with atrial fibrillation – insights from a cohort study of 7,412 patients with extended follow-up	51
Impact of COVID-19 pandemics on the incidence and mortality in Takotsubo syndrome: a report from Swedish Coronary Angiography and Angioplasty Registry	51
Early quantitative pupillary response parameters have high predictive value for 30-day mortality in patients resuscitated from out-of-hospital cardiac arrest	51
Early Intervention with Impedance-guided Heart Failure Management Improves Long-term Outcome: insights From the IMPEDANCE-HF Trial	51
Induction of RAGE-NFkB signalling axis enhances SHP-2 tyrosine phosphatase expression resulting in deviant activation of diabetic monocytes	50
Retracted: Cardiovascular risk profile of a young adult population with high risk for obstructive sleep apnea screened by Stop-Bang and Epworth sleepiness scale in a primary health care unit	50
Left atrial appendage perimeter ostium evaluation by cardiac CT utilizing 3mensio technology for watchman implantation	49
Differential efficacy and safety of oral anticoagulation in atrial fibrillation patients with or without comorbid vascular disease: insights from the GARFIELD-AF registry	49
Determination of left ventricular diastolic dysfunction using machine learning methods	49
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction	49
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials	49
Validity and utility of the questionnaire-based FRAIL scale in elderly patients with heart failure: findings from the FRAGILE-HF	49
Cardiovascular etiologies and risk factors of survival outcomes after resuscitation for out-of-hospital cardiac arrest: data from the KoCARC registry	48
Much ado about nothing: the impact of coronary angiography on kidney function in individuals with chronic kidney disease	48
Artificial intelligence-assisted examination of cardiac health status through electrocardiogram	48
The role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in epicardial adipose tissue modulation: a meta-analysis	48
The impact of mitral regurgitation grade on exercise capacity following cardiac rehabilitation program after transcatheter aortic valve implantation	48
A larger reduction of spatial mean QRS-T angle during cardiac resynchronisation therapy is associated with a lower risk of mortality and heart failure hospitalisation	48